Each filer's latest filing for 12529R107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Lynx1 Capital Management LP
13G/A
|
10.0% |
8/14/2026
Event 6/30/2026
|
||
| Lynx1 Capital Management LP | 10.0% | |||
| Weston Nichols | 10.0% | |||
|
Soleus Capital Master Fund, L.P.
13G/A
|
10.0% |
2/12/2026
Event 12/31/2025
|
||
| Soleus Private Equity Fund III, L.P. | 5.9% | |||
| Soleus Private Equity GP III, LLC | 5.9% | |||
| Soleus PE GP III, LLC | 5.9% | |||
| Soleus Capital Master Fund, L.P. | 10.0% | |||
| Soleus Capital, LLC | 10.0% | |||
| Soleus Capital Group, LLC | 10.0% | |||
| Soleus Capital Management, L.P. | 10.0% | |||
| Soleus GP, LLC | 10.0% | |||
| Guy Levy | 10.0% | |||
|
Sirenia Capital Management LP
13G
|
9.9% |
5/15/2026
Event 3/31/2026
|
||
| Sirenia Capital Management LP | 9.9% | |||
| Alex Silverstein | 9.9% | |||
|
RA Capital Management, L.P.
13G/A
|
9.9% |
11/16/2026
Event 9/30/2026
|
||
| RA Capital Management, L.P. | 9.9% | |||
| Peter Kolchinsky | 9.9% | |||
| Rajeev Shah | 9.9% | |||
| RA Capital Healthcare Fund, L.P. | 9.9% | |||
|
Squadron Capital Management LLC
13G/A
|
7.9% |
11/16/2026
Event 9/30/2026
|
||
| Squadron Master Fund LP | 7.9% | |||
| Squadron Capital Management LLC | 7.9% | |||
| Matthew Sesterhenn | 7.9% | |||
| William Blank | 7.9% | |||
| BlackRock, Inc. 13G | 6.9% |
7/27/2026
Event 6/30/2026
|
||
|
Bain Capital Life Sciences Fund II, L.P.
13G
|
6.3% |
10/24/2025
Event 10/17/2025
|
||
| Bain Capital Life Sciences Fund II, L.P. | 1.1% | |||
| BCIP Life Sciences Associates, LP | 0.1% | |||
| BCLS II Equity Opportunities, LP | 6.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Morgan Stanley
13G/A
|
8.0%
Checked 5% or less
|
8/12/2026
Event 6/30/2026
|
||
| Morgan Stanley | 8.0% | |||
| Morgan Stanley Capital Services LLC | 7.9% | |||
| Morgan Stanley & Co. LLC | 0.1% | |||
| Wasatch Advisors LP 13G/A | 4.7% |
4/22/2026
Event 3/31/2026
|
||
|
OrbiMed Advisors LLC
13G/A
|
1.0% |
2/17/2026
Event 12/31/2025
|
||
| OrbiMed Advisors LLC | 0.5% | |||
| OrbiMed Capital LLC | 1.0% | |||
|
Point72 Asset Management, L.P.
13G/A
|
0.2% |
5/15/2026
Event 3/31/2026
|
||
| Point72 Asset Management, L.P. | 0.2% | |||
| Point72 Capital Advisors, Inc. | 0.2% | |||
| Steven A. Cohen | 0.2% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 152 | 138 M | $457M |
| 2026 Q2 | 148 | 118 M | $548M |
| 2026 Q1 | 123 | 84.5 M | $221M |
| 2025 Q4 | 101 | 79.8 M | $153M |
| 2025 Q3 | 99 | 52.5 M | $117M |
| 2025 Q2 | 103 | 54.7 M | $78.2M |
| 2025 Q1 | 116 | 64.1 M | $103M |
| 2024 Q4 | 117 | 64.4 M | $232M |
| 2024 Q3 | 122 | 64.2 M | $366M |
| 2024 Q2 | 116 | 60.9 M | $281M |
| 2024 Q1 | 107 | 58.2 M | $476M |
| 2023 Q4 | 93 | 47.0 M | $266M |
| 2023 Q3 | 85 | 34.7 M | $64.5M |
| 2023 Q2 | 101 | 34.2 M | $94.1M |
| 2023 Q1 | 122 | 37.4 M | $117M |
| 2022 Q4 | 118 | 39.2 M | $231M |
| 2022 Q3 | 116 | 39.4 M | $346M |
| 2022 Q2 | 119 | 39.4 M | $298M |
| 2022 Q1 | 127 | 37.3 M | $905M |
| 2021 Q4 | 123 | 35.9 M | $1.15B |
| 2021 Q3 | 115 | 34.5 M | $1.54B |
| 2021 Q2 | 110 | 31.9 M | $1.21B |
| 2021 Q1 | 85 | 25.1 M | $927M |
| 2020 Q4 | 76 | 22.7 M | $744M |